153 related articles for article (PubMed ID: 36834887)
21. Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway.
Zhang J; Xu HX; Cho WCS; Cheuk W; Li Y; Huang QH; Yang W; Xian YF; Lin ZX
J Exp Clin Cancer Res; 2022 Mar; 41(1):90. PubMed ID: 35272669
[TBL] [Abstract][Full Text] [Related]
22. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway.
Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R
J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958
[TBL] [Abstract][Full Text] [Related]
23. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells.
Panieri E; Saso L
Antioxid Redox Signal; 2021 Jun; 34(18):1428-1483. PubMed ID: 33403898
[No Abstract] [Full Text] [Related]
25. Pin1 aggravates renal injury induced by ischemia and reperfusion in rats via Nrf2/HO-1 mediated endoplasmic reticulum stress.
Yu H; Jiang G; Hu W; Xu C
Acta Cir Bras; 2022; 37(1):e370101. PubMed ID: 35416857
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial Calcium Uniporter Drives Metastasis and Confers a Targetable Cystine Dependency in Pancreatic Cancer.
Wang X; Li Y; Li Z; Lin S; Wang H; Sun J; Lan C; Wu L; Sun D; Huang C; Singh PK; Hempel N; Trebak M; DeNicola GM; Hao J; Yang S
Cancer Res; 2022 Jun; 82(12):2254-2268. PubMed ID: 35413105
[TBL] [Abstract][Full Text] [Related]
27. The prolyl isomerase Pin1 increases β-cell proliferation and enhances insulin secretion.
Nakatsu Y; Mori K; Matsunaga Y; Yamamotoya T; Ueda K; Inoue Y; Mitsuzaki-Miyoshi K; Sakoda H; Fujishiro M; Yamaguchi S; Kushiyama A; Ono H; Ishihara H; Asano T
J Biol Chem; 2017 Jul; 292(28):11886-11895. PubMed ID: 28566287
[TBL] [Abstract][Full Text] [Related]
28. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.
Fishel ML; Wu X; Devlin CM; Logsdon DP; Jiang Y; Luo M; He Y; Yu Z; Tong Y; Lipking KP; Maitra A; Rajeshkumar NV; Scandura G; Kelley MR; Ivan M
J Biol Chem; 2015 Jan; 290(5):3057-68. PubMed ID: 25492865
[TBL] [Abstract][Full Text] [Related]
29. Generation of an in vitro 3D PDAC stroma rich spheroid model.
Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
[TBL] [Abstract][Full Text] [Related]
30. Critical role of XBP1 in cancer signalling is regulated by PIN1.
Chae U; Park SJ; Kim B; Wei S; Min JS; Lee JH; Park SH; Lee AH; Lu KP; Lee DS; Min SH
Biochem J; 2016 Sep; 473(17):2603-10. PubMed ID: 27334111
[TBL] [Abstract][Full Text] [Related]
31. JNK inhibition blocks piperlongumine-induced cell death and transcriptional activation of heme oxygenase-1 in pancreatic cancer cells.
Mohammad J; Singh RR; Riggle C; Haugrud B; Abdalla MY; Reindl KM
Apoptosis; 2019 Oct; 24(9-10):730-744. PubMed ID: 31243599
[TBL] [Abstract][Full Text] [Related]
32. Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway.
Qaisiya M; Coda Zabetta CD; Bellarosa C; Tiribelli C
Cell Signal; 2014 Mar; 26(3):512-20. PubMed ID: 24308969
[TBL] [Abstract][Full Text] [Related]
33. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
DeNicola GM; Karreth FA; Humpton TJ; Gopinathan A; Wei C; Frese K; Mangal D; Yu KH; Yeo CJ; Calhoun ES; Scrimieri F; Winter JM; Hruban RH; Iacobuzio-Donahue C; Kern SE; Blair IA; Tuveson DA
Nature; 2011 Jul; 475(7354):106-9. PubMed ID: 21734707
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.
Geismann C; Morscheck M; Koch D; Bergmann F; Ungefroren H; Arlt A; Tsao MS; Bachem MG; Altevogt P; Sipos B; Fölsch UR; Schäfer H; Müerköster SS
Cancer Res; 2009 May; 69(10):4517-26. PubMed ID: 19435915
[TBL] [Abstract][Full Text] [Related]
35. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer.
Li Y; Zhao Z; Lin CY; Liu Y; Staveley-OCarroll KF; Li G; Cheng K
Theranostics; 2021; 11(5):2182-2200. PubMed ID: 33500719
[No Abstract] [Full Text] [Related]
36. CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma.
Morita T; Kodama Y; Shiokawa M; Kuriyama K; Marui S; Kuwada T; Sogabe Y; Matsumori T; Kakiuchi N; Tomono T; Mima A; Ueda T; Tsuda M; Yamauchi Y; Nishikawa Y; Sakuma Y; Ota Y; Maruno T; Uza N; Nagasawa T; Chiba T; Seno H
Cancer Res; 2020 Oct; 80(19):4058-4070. PubMed ID: 32606001
[TBL] [Abstract][Full Text] [Related]
37. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming.
Zhao T; Zhang R; He Q; Zhou H; Song X; Gong T; Zhang Z
Acta Biomater; 2022 Jun; 145():122-134. PubMed ID: 35381402
[TBL] [Abstract][Full Text] [Related]
38. Measurement of Reactive Oxygen Species by Fluorescent Probes in Pancreatic Cancer Cells.
Luo Y; Wang D; Abbruzzese JL; Lu W
Methods Mol Biol; 2019; 1882():207-219. PubMed ID: 30378057
[TBL] [Abstract][Full Text] [Related]
39. Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome.
Su H; Yang F; Fu R; Trinh B; Sun N; Liu J; Kumar A; Baglieri J; Siruno J; Le M; Li Y; Dozier S; Nair A; Filliol A; Sinchai N; Rosenthal SB; Santini J; Metallo CM; Molina A; Schwabe RF; Lowy AM; Brenner D; Sun B; Karin M
Nature; 2022 Oct; 610(7931):366-372. PubMed ID: 36198801
[TBL] [Abstract][Full Text] [Related]
40. The protein level and transcription activity of activating transcription factor 1 is regulated by prolyl isomerase Pin1 in nasopharyngeal carcinoma progression.
Huang GL; Liao D; Chen H; Lu Y; Chen L; Li H; Li B; Liu W; Ye C; Li T; Zhu Z; Wang J; Uchida T; Zou Y; Dong Z; He Z
Cell Death Dis; 2016 Dec; 7(12):e2571. PubMed ID: 28032861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
